ArticlePDF Available

Association of lipoprotein subclasses and carotid intima-media thickness in the Chinese population

Authors:
  • Hulhumale Hospital Maldives

Abstract and Figures

Aims: To determine whether lipoprotein subclasses are associated with the carotid intima-media thickness (IMT) in Chinese population. Patients & methods: Total cholesterol (TC), triglycerides, high-density lipoprotein-cholesterol (HDL-C) and low-density lipoprotein-cholesterol (LDL-C) were measured by standard enzymatic methods. The subclasses of LDL were determined by 1D gradient gel electrophoresis and subclasses of HDL were determined by 2D gradient gel electrophoresis in 342 participants. Carotid IMT was measured by means of high-resolution vascular ultrasound. Results: In multivariate analysis, TC and LDL-C levels were positively correlated with the carotid IMT (p < 0.001). In stepwise multiple regression analysis, small dense LDL was found to be significantly associated with IMT after adjustment for other metabolic risks and traditional lipids such as triglycerides, TC and HDL-C. Additionally, HDL subclasses were not correlated with IMT. Conclusion: Small dense LDL was a stronger predictor for carotid atherosclerosis in the general Chinese population when compared with HDL-C or HDL subclasses, which is independent of lipids and other related metabolic risks.
Content may be subject to copyright.
407
ISSN 1758-4299
Clin. Lipidol. (2014) 9(4), 407– 415
part of
Research Article Clinical Lipidology
Association of lipoprotein subclasses and
carotid intima-media thickness in the
Chinese population
Aims: To determine whether lipoprotein subclasses are associated with the carotid
intima-media thickness (IMT) in Chinese population. Patients & methods: Tot al
cholesterol (TC), triglycerides, high-density lipoprotein-cholesterol (HDL-C) and
low-density lipoprotein-cholesterol (LDL-C) were measured by standard enzymatic
methods. The subclasses of LDL were determined by 1D gradient gel electrophoresis
and subclasses of HDL were determined by 2D gradient gel electrophoresis in
342 participants. Carotid IMT was measured by means of high-resolution vascular
ultrasound. Results: In multivariate ana lysis, TC and LDL-C levels were positively
correlated with the carotid IMT (p < 0.001). In stepwise multiple regression ana lysis,
small dense LDL was found to be significantly associated with IMT after adjustment
for other metabolic risks and traditional lipids such as triglycerides, TC and HDL-C.
Additionally, HDL subclasses were not correlated with IMT. Conclusion: Small dense
LDL was a stronger predictor for carotid atherosclerosis in the general Chinese
population when compared with HDL-C or HDL subclasses, which is independent of
lipids and other related metabolic risks.
KEYWORDS: carotid intima-media thickness • Chinese • high-density lipoprotein subclasses
• lipid • low-density lipoprotein subclasses
Low-density lipoprotein-cholesterol (LDL-
C), a hallmark for risk assessment, has been
thought to be the primary target of lipid-
lowering therapy in the National Choles-
terol Education Program – Adult Treatment
Panel III. However, using the indicator of
LDL-C alone is insufficient to identify indi-
viduals with severe stable coronary heart dis-
ease (CHD), since these subjects have lower
LDL-C concentrations [1] . Thus, small dense
LDL (sdLDL) particles have been considered
to be another important factor in monitor-
ing the adequacy of a patient’s lipid-lowering
therapy. Many studies even revealed that car-
diovascular disease (CVD) is more strongly
related to sdLDL than LDL-C [2] . Interest-
ingly, several studies have shown that sdLDL
measured by nondenaturing polyacrylamide
gradient gel electrophoresis (GGE) was also
significantly associated with asymptomatic
carotid atherosclerosis in Type 2 diabetes [3] .
In addition, the inverse relation-
ship between high-density lipoprotein–C
(HDL-C) and CVD risk is well accepted in
epidemiological surveys [4]. However, contro-
versy still remains as to whether HDL sub-
classes play anti-inflammatory roles in anti-
atherogenesis. HDL is a heterogeneous class
of lipoproteins, which differ by their density,
size, electrophoretic mobility, apolipoprotein
content and associated enzymes. The multi-
ple enzymes associated with HDL particles,
including paraoxonase, glutathione peroxidase
and platelet-activating factor acetylhydrolase,
normally have antioxidant properties [5] . They
can modify atherogenic reactive oxygen spe-
cies in the vessel wall. While in the presence
of systemic inflammation, these enzymes were
then modified by reactive oxygen to be inac-
tive. Thus, the enzymatic changes in HDL
particles can impede cholesterol efflux and
induce the proinflammation in atherosclerosis.
Fangfang Yan1,2, Li Tian2,
Huangdao Yu2, Attit Baskota1,
Yun Gao1, Sheyu Li1, Mingde
Fu2 & Haoming Tian*,1
1Department of Endocrinology
& Metabolism, West China Hospital of
Sichuan University, Chengdu,
610041 Sichuan, P. R. China
2Laboratory of Endocrinology
& Metabolism, West China Hospital of
Sichuan University, Chengdu,
610041 Sichuan, P. R. China
*Author for correspondence:
Tel.: +86 02885422982
Fax: +8 6 02885423459
haomingtian666@126.com
Research Article
10.2217/CLP.14.22 © 2014 Future Medicine Ltd
For reprint orders, please contact: reprints@futuremedicine.com
408 Clin. Lipidol. (2014) 9(4)
Furthermore, their physical characteristics were relevant
to their differential effects on the risk of CHD [6] . Stud-
ies revealed that pre-beta1-HDL was positively corre-
lated with carotid atherosclerosis [7] , while HDL2 and
HDL3 were inversely correlated with vascular disease
[8]. Recently, this concept has been challenged by sev-
eral studies demonstrating that the large HDL particles
showed a negative association with retinopathy, but no
relationship was seen to macrovascular risk [9].
Indeed, the standardization for the various analytic
methodologies achieving HDL separation is still lack-
ing. The early work with the analytical ultracentrifu-
gation led to the characterization of lipoprotein sub-
classes based on their ultracentrifugal flotation rates in
high-salt solutions. Recently, GGE delineated multiple
physically distinguished LDL and HDL subclasses,
ranging from very large to very small particles. There-
fore, it is reasonable to expect less than perfect inte-
rassay agreement. This may explain in part the con-
flicting results on the correlation of HDL subclasses
with vascular disease in epidemiological studies and
clinical trials [10 ] .
To date, only a few cross-sectional studies have
directly assessed the association of lipoprotein sub-
classes and carotid atherosclerosis. Alagona et al.
measured HDL subfractions by ultracentrifugation
and found that neither HDL2-C nor HDL3-C was
significantly related to carotid intima-media thick-
ness (IMT) [11] . In addition, a 481 Japanese-Ameri-
can study also revealed that higher HDL2-C level
measured by precipitation was better protected from
atherosclerosis. However, the significant relation-
ship between HDL2-C and carotid atherosclerosis
disappeared after further adjustment for age and sex
[12 ] . Therefore, our study aims to observe the distri-
bution of lipoprotein particles and the relationship
of lipoprotein particles subclasses with the carotid
IMT in the Chinese population, and to confirm that
this relationship is independent of lipids and other
metabolic risks.
Participants & methods
Participants
This study is a part of a long-term prospective epide-
miological survey initiated in 2007. Hereby, we pre-
sent the data that investigate social determinants of
health, specifically the prevalence of diabetes and vas-
cular diseases in Chinese patients during follow-up
within the year of 2009. The epidemiological survey
was previously described in detail elsewhere [13 ] . After
a 12-h fasting, venous blood was drawn and samples
were stored at -70°C, plasma lipid concentrations
(total cholesterol [TC], triglycerides [TG] and HDL-
C) were measured as described previously [1 4] . When
TG 4.52 mmol/l, LDL-C was measured by standard
enzymatic methods (Roche Diagnostics). The Fried-
wald formula was used when TG <4.52 mmol/l [15 ] .
ApoA1 and apoB100 were assessed by immunoneph-
elometric methods (Roche Diagnostics). To study the
correlation between the LDL-C/HDL-C ratio and
lipoprotein subclass distribution, subjects were strati-
fied into three subgroups according to the tertiles
of LDL-C/HDL-C. The cut-off points were: lower
than 1.5, 1.5 to 2.0 and higher than 2.0.
Our study included 342 subjects, which consisted
of 168 men and 174 women, aged 20–75 years. Eli-
gible participants were free of any drugs affecting
the lipid metabolism and were recruited from the
same community at Chengdu, Sichuan province
in 2009. Diagnosis of diabetes mellitus was based
on the revised 1999 WHO criteria as follows: fast-
ing plasma glucose level 126 mg/dl; plasma glucose
200 mg/dl 2 h after a 75 g oral glucose load as in a
glucose tolerance test. A repeat of any of the above
methods should be taken on a different day. Hyper-
tension is defined as a systolic blood pressure consist-
ently higher than 140 mmHg and/or a diastolic blood
pressure consistently higher than 90 mmHg. Smok-
ers were defined as having smoked at least 100 ciga-
rettes during their lifetimes. Alcohol drinking was
defined as the consumption of at least 30 g of alco-
hol per week for 1 year or more. All subjects signed
informed consent forms. The Drugs/Medical Appa-
ratus & Instruments Ethics Committee at China
Japan Friendship Hospital (07020470055) approved
the study protocol and the registration number is
#TR-CCH-Chi CTR-CCH-00000361.
Carotid ultrasound measurements
Carotid IMT was measured by means of high-resolu-
tion vascular ultrasound (Philips ATL 3500 device).
We used the mean of eight measurements of maximal
IMT (right and left common carotid arteries, three
longitudinal views of each internal carotid arteries)
[16 ] . All imaging studies were transmitted to a central
reading center for interpretation.
Lipoprotein subclasses measurement
HDL subclasses were measured by 2D GGE coupled
with immunoblotting, as previously described [1 4] .
Then, HDL subclasses can be classified into small
discoidal HDL (Preb-1HDL and Preb-2HDL),
intermediate spherical HDL3 (HDL3c, HDL3b
and HDL3a) and large mature HDL2 (HDL2a
and HDL2b).
LDL subclasses size was measured by 2–16%
gradient polyacrylamide gel electrophoresis (GGE),
as described [17] . LDL subclasses were classified by
future science group
Research Article Yan, Tian, Yu et al.
www.futuremedicine.com 409
their diameters into small (<25.5 nm), intermedi-
ate (25.5–26.0 nm) and large (>26.0 nm), as LDL1,
LDL2 and LDL3, respectively.
Statistical methods
Data are presented as mean + SD. TG and IMT
measurements were log-transformed to normalized
distribution. A multiple comparison test (least sig-
nificant difference) was used to compare lipopro-
tein subclass distribution across the tertiles of TG
or LDL-C/HDL-C. Univariate ana lysis was used to
assess the independent associations of baseline clini-
cal and laboratory characteristics with carotid IMT.
Additionally, three multivariate regression models
were then performed using the mean IMT as the
dependent variable. The first model included lipopro-
tein subclasses, age, sex, BMI, smoking and alcohol
drinking. A second multivariate regression model also
included blood pressure and hemoglobin A1c, and a
third model also included lipid parameters (TG, TC
and HDL-C). Statistical significance was considered
at p < 0.05.
Results
Characteristic of subgroups classified based on gender
are presented in Ta ble 1. The prevalence of diabetes,
hypertension and dyslipidemia in the male group was
similar to that in the female group. The smoking rate
among males was 46.7%, while it was 3.7% in females.
The percentage of alcohol drinking in males was four-
to five-times more than that in females. The levels of
TG in the male group was significantly higher than
that in the female group, and the females also had the
lower HDL-C levels. 18 patients with diabetes received
insulin or oral antidiabetic drugs, 42 patients with
hypertension received antihypertensive drugs, and
seven dyslipidemic patients received statins or fibrates
therapy.
Table 1. Characteristics of participants.
Characteristic Male (n = 152) Female (n = 190)
Age (years) 49.9 ± 13. 8 47. 7 ± 12.8
BMI ( kg /cm2)24.2 ± 3.6 23.3 ± 3.4*
Smokers, n (%) 71 (4 6.7) 7 (3.7)***
Alcohol drinking, n (%) 36 (23.68 (4.2)***
Diabetes, n (%) 15 (9.9 ) 16 (8.4)
Hypertension, n (%) 29 (19.0 ) 32 (16.8)
Dyslipidemia, n (%) 18 (11 . 8 ) 24 (12 .6 )
Hb A1c (%) 5.7 ± 1.0 5.5 ± 0.4
SBP (mmHg) 122.1 ± 18.3 115 . 2 ± 21.5
DBP (mmHg) 79.3 ± 9.8 73.6 ± 10.9
TG (mg /dl132.8 ± 97. 4 106.2 ± 70.8*
TC (mg /dl181.7 ± 30.9 185.6 ± 38.7
HD L- C ( m g / dl5 7.7 ± 15.4 61.5 ± 11.5**
LD L- C (mg/dl111.9 ± 30.5 108.0 ± 34 .7
Small dense LDL (%) 38.2 ± 17.7 34.4 ± 17.7
Intermediate dense LDL (%) 27. 8 ± 7.1 27. 9 ± 7.3
Large dense LDL (%) 34.1 ± 17. 7 3 7.7 ± 17.7
Preb1-HDL (mg /dl) 93.2 ± 16.5 86.5 ± 14.0***
Preb2-HDL (mg /dl) 42.4 ± 9.1 41.9 ± 8.1
HDL3c (mg/dl) 7 7. 0 ± 9.5 76.0 ± 9.3
HDL3b (mg/dl) 120.0 ± 21.2 118.2 ± 21.2
HDL3a (mg/ dl) 173 .5 ± 25.3 172 .1 ± 22.2
HDL2a (mg/ dl) 19 7.9 ± 17.4 201.6 ± 16 .4*
HDL2b (mg/dl) 281.2 ± 30.6 289.5 ± 29.8*
*p < 0.05; **p < 0.01; ***p < 0.001.
DBP: Diastolic blood pressure; HbA1c: Hemoglo bin A1c; HDL-C: High-density lipoprotein-cholesterol; L DL-C: Low-density
lipoprotein -cholesterol; SBP: Systolic blo od pressure ; TC: Total cholesterol ; TG: Triglycerides.
future science group
Association of lipoprotein subclasses & carotid intima-media thickness in the Chinese population Research Article
410 Clin. Lipidol.(2014) 9(4)
Relationship of lipoprotein particles subclasses
with levels of TG
The size of LDL particles was inversely correlated with
the levels of TG in Ta bl e 2. TG levels were significantly
positively correlated with sdLDL, but inversely
correlated with large dense LDL. In addition, the dis-
tribution of HDL subclasses was not related to the
levels of TG.
Relationship between the concentrations of
lipids, lipoprotein subclasses & the LDL-C/HDL-C
ratio
The relationships of the distribution of lipoprotein
particles subclasses with serum LDL-C/HDL-C ter-
tiles are shown in Tab l e 3 . Compared with those in the
lower tertile of LDL-C/HDL-C ratios, participants in
the upper tertile had higher levels of TC, TG and LDL-
Table 2. Association of lipoprotein particles subclasses and triglycerides.
TG 77. 9 (mg /dl ) 77.9 < TG <118.6 (mg /dl) TG 118.6 ( mg/dl)
Small dense LDL (%) 29.2 ± 15.0 33.6 ± 16.3 44.0 ± 19.0******
Intermediate dense LDL (%) 28.0 ± 7. 6 28.1 ± 6.0 27. 3 ± 7. 8
Large dense LDL (%) 42 .1 ± 17.1 38.1 ± 16.9 28.8 ± 16.8******
Preβ1-HDL (mg /dl) 89.2 ± 12.7 86.7 ± 15. 2 91.0 ± 17.0*
Preβ2-HDL (mg /dl) 40.8 ± 9.3 43 .1 ± 8.3*42.5 ± 7.6
HDL3c (mg/dl) 77. 3 ± 9.1 75.9 ± 9.7 76.0 ± 9.3
HDL3b (mg/dl) 119.7 ± 21.6 119.1 ± 21.6 118.8 ± 20.0
HDL3a (mg/ dl) 174 .5 ± 22.3 172.2 ± 22.8 171.8 ± 25.0
HDL2a (mg/ dl) 199.1 ± 16.9 200.9 ± 16.8 200.6 ± 16.9
HDL2b (mg/dl) 285.8 ± 31.6 288.9 ± 29.5 283.4 ± 30.0
*p < 0.05; ***p < 0.001.
Signicant difference between TG 118.6 group and TG 77.9 group.
Signicant difference between TG 118.6 and 77.9 < TG <118.6 group.
HDL: High -densit y lipoprotein; LDL: Low -densit y lipoprotein; TG: Triglyceride s.
Table 3. Association of lipids and lipoprotein particles subclasses and low-density
lipoprotein-cholesterol /high-density lipoprotein-cholesterol.
LDL-C/HDL-C 1.5
(n = 118)
1.5 <LDL-C/HDL-C <2.0
(n = 104)
LDL-C/HDL-C 2.0
(n = 120)
TG (mg /dl)88.5 ± 44.3 106. 2 ± 53.1 159.4 ± 115.1***§***
TC (mg /dl) 162.4 ± 30.9 17 7. 9 ± 27.1*** 205.0 ± 38.7***§***
LD L- C ( m g / dl)81.1 ± 19.3 104.3 ± 19.3*** 13 9.1 ± 30.9***§***
HD L- C ( m g / dl) 73.1 ± 11. 5 61.5 ± 11. 5*** 53.8± 7.7 ***§***
Small dense LDL (%) 26.0 ± 14.2 32 .1 ± 12. 2** 47. 9 ± 18.2***§***
Intermediate dense LDL (%) 27.1 ± 6.5 30.2 ± 6.5** 26.2 ± 7.8 §***
Large dense LDL (%) 46.9 ± 16.4 37.7 ± 14.6*** 25.9 ± 15.7***§***
Pre-beta1-HDL (mg/dl) 83.9 ± 14.8 89.2 ± 13 .3** 93.4 ± 16 .0***§*
Pre-beta2- HDL (mg/dl) 41.5 ± 8.2 42.1 ± 8 .1 42.6 ± 9.0
HDL3c (mg/dl) 76.8 ± 9.0 76.0 ± 9.1 76.4 ± 10.0
HDL3b (mg/dl) 116 . 6 ± 22.4 120.5 ± 20.6 119.5 ± 20.5
HDL3a (mg/ dl) 171.4 ± 23.3 174.0 ± 22.2 172 .5 ± 24.5
HDL2a (mg/ dl) 203.5 ± 17.1 199.8 ± 15.9 197.7 ± 17.1*
HDL2b (mg/dl) 2 97.1 ± 3 0 .1 283.8 ± 29.9** 279.0 ± 27. 8 ***
Values are expre ssed as mean ± s tandard deviation.
*p < 0.05; **p < 0.01; ***p < 0.001.
These variables were analyzed with log10 transformation.
Signicantly different from LDL-c/ HDL-c 1.5 group.
§Signicantly different from 1.5 <LDL-C/ HDL-c <2.0 group.
HDL-C: High- density lipoprotein- cholesterol; LDL-C, Low-densit y lipoprotein -cholesterol; TC: Total cholesterol; TG: Triglycerides.
future science group
Research Article Yan, Tian, Yu et al.
www.futuremedicine.com 411
C, and lower HDL-C levels. Participants in the upper
tertile also had an increased level of pre-beta1-HDL
and decreased levels of HDL2 (HDL2a and HDL2b).
They also had an elevated level of LDL1.
Relationship between concentrations of lipids
& carotid IMT
To investigate the factors of vascular risk, we performed
correlation ana lysis with carotid IMT as a dependent
variable and the levels of lipid parameters including
lipoprotein subclasses as independent variables. We
found that IMT was significantly positively correlated
with TC and LDL, but no correlation with TG and
HDL-C was seen (Figure 1A D) .
Relationship between lipoprotein subclasses
& carotid IMT
The lipoprotein subclasses distribution is shown in
Tab le 4. The major subclasses of HDL were HDL2
(HDL2a and HDL2b) and HDL3a, whereas there
was no significant difference in LDL subclasses
distribution. In univariate correlations, the spearman’s
1.40
1.20
1.00
0.80
0.60
0.40
IMT (mm)
LDL-C (mmol/l)
2.00 4.00 6.00 8.00
r = 0.28
p < 0.001
1.40
1.20
1.00
0.80
0.60
0.40
IMT (mm)
HDL-C (mmol/l)
0.50 1.00 1.50 2.00 2.50 3.00
r = -0.02
p = 0.07
1.40
1.20
1.00
0.80
0.60
0.40
IMT (mm)
TC (mmol/l)
2.000.00 4.00 6.00 8.00 10.00
r = 0.28
p < 0.001
1.40
1.20
1.00
0.80
0.60
0.40
IMT (mm)
TG (mmol/l)
2.000.00 4.00 6.00 8.00
r = 0.09
p = 0.11
AB
C D
Figure 1. Univariate correlation of intima -media thickness with lipids in all subjects. (A) Positive correlation
between LDL-C and carotid IMT. (B) Positive correlation between TC and carotid IMT. (C) No correlation between
HDL-C and carotid IMT. (D) No significant correlation between TG and carotid IMT.
HDL-C: High-density lipoprotein- cholesterol; IMT: Intima-media thickness; LDL-C: Low-density
lipoprotein-cholesterol ; TC: Total cholesterol; TG: Triglycerides.
future science group
Association of lipoprotein subclasses & carotid intima-media thickness in the Chinese population Research Article
412 Clin. Lipidol.(2014) 9(4)
correlation coef cients of IMT with lipoprotein
subclasses were 0.3 for LDL1 and -0.24 for LDL3, as
shown in Tabl e 2 . No association was found between
HDL subclasses and IMT.
Additionally, the independent association of LDL
subclasses with carotid IMT was tested by several
multivariate regression models. Higher serum LDL1
levels were associated with increased IMT, independ-
ent of age and sex. When this association was also
adjusted for conventional risk factors (model 3), higher
serum LDL1 remained a signicant positive predic-
tor of carotid atherosclerosis. The adjusted standard
regression coefficient (b values) was 0.107 for LDL1
(Tab le 5 ). Interestingly, an independent association
between LDL3 and IMT disappeared.
Discussion
Several epidemiologic studies have demonstrated that
LDL-C is an important marker for CHD. However,
almost half of all patients with CHD have normal
LDL-C levels. The Japanese study has shown that
LDL-C/HDL-C ratios have predictive value for
residual risk of acute myocardial infarction/sudden
death when LDL-C levels <120 mg/dl [18].
In our results, we also observed that TC, TG and
LDL-C levels increased, but HDL-C level decreased
significantly when the ratio of LDL-C/HDL-C
increased. The present results also showed the high-
est LDL-C/HDL-C tertile was significantly associated
with smaller LDL and HDL subclasses.
The alteration of lipoprotein subclasses distribu-
tion may be explained by the impaired cholesterol ester
transfer protein (CETP) activity and enhanced hepatic
lipase activity. It is reported that a significant increase
of TG is observed in high LDL-C/HDL-C ratio. At
the same time, several epidemiological studies revealed
that high levels of TG were associated with impaired
CETP activity [19 ] . CETP mainly transfers CE from
HDL2 to LDL in exchange for TG. Thus, CETP
plays an important role in the conversion of HDL2 to
Table 4. Association of lipoprotein subclasses by univariate correlation analysis with intima-media
thickness.
Lipoprotein subclasses Concentrations Rp-value
LD L- C / H DL-C 1.9 ± 0.7 0.254 < 0.001
LDL subclasses
Small dense LDL (%) 35.8 ± 17.7 0.30 <0.001
Intermediate dense LDL (%) 27.8 ± 7. 2 - 0.13 0.02
Large dense LDL (%) 36.4 ± 17.8 -0.24 <0.001
HDL subclasses
Pre-beta1-HDL (mg/l) 89.0 ± 15.3 -0.01 >0.05
Pre-beta2-HDL (mg /l) 42.1 ± 8.5 -0.06 >0.05
HDL3c (mg/l) 76.4 ± 9.4 - 0 .11 0.06
HDL3b (mg/l) 119.0 ± 21.1 0.01 >0.05
HDL3a (mg/l) 172.7 ± 23.3 0 >0.05
HDL2a (mg/l) 200.2 ± 16.8 0 >0.05
HDL2b (mg/ l) 286.4 ± 30.4 0 >0.05
Values are presented as mean ± standard deviation.
HDL-C: High- density lipoprotein- cholesterol; LDL-C: Low-density lipoprotein-choles terol.
Table 5. Association of l ow-density lipoprotein 1 levels by stepwise multiple regression analysis with
intima-media thickness after adjusting for clinical characteristics and other lipids.
Adjustment Beta p-value
Small dense LDL 0.3 <0.001
Adjusted for age, sex, BMI, smoking and alcohol drinking 0.117 0 .013
Adjusted for age, sex, BMI, smoking, alcohol drinking, blood
pressure and HbA1c
0.1 07 0.030
Adjusted for all above plus lipids (TG, TC, HDL-C) 0 .107 0.031
HbA1c: Hemoglobin A1c; HDL-C: High-d ensity lipoprotein-cholestero l; LDL: Low-density lipoprotein; TC: Total cholesterol; TG: Triglycerides.
future science group
Research Article Yan, Tian, Yu et al.
www.futuremedicine.com 413
pre-beta1-HDL [20] . On the other hand, hydrolysis of
LDL-TG by hepatic lipase increases sdLDL (LDL1)
concentration. In this regard, the LDL-C/HDL-C
ratio may be a good indicator for the distribution of
lipoprotein subclasses.
Furthermore, our results also showed that TC and
LDL levels had positive correlations with the risk of
carotid atherosclerosis. Additionally, we investigated
the relationship between lipoprotein subclasses and
carotid atherosclerosis after adjustment for smok-
ing, alcohol drinking, lipid, age, pressure, BMI and
hemoglobin A1c. As a result, sdLDL was found to be
significantly and independently associated with IMT.
These findings support previous research, which
showed that LDL-C is the primary goal of treatment in
lipid management. A number of well-designed epidemi-
ological and clinical studies reported that LDL-C is an
independent risk in macrovascular disease. A Heart Pro-
tection Study Collaborative Group trial also reported
that reducing LDL-C level by allocating simvastatin
can reduce the incidence of vascular disease, irrespective
of their initial cholesterol concentrations. [ 21] . However,
the effect of LDL-C on the process of atherosclerosis
may depend on lipoprotein subclasses. It is more likely
for sdLDL to enter the endothelium, become oxidized
and trigger the atherosclerosis progression. In the cur-
rent study, sdLDL is also an established independent
indicator for carotid IMT in the general Chinese popu-
lation, which is identical to that which was observed
in a Genetics of Coronary Artery Disease in Alaska
Natives study [2 2]. The Framingham Offspring cohort
also found that LDL particle number (LDL-P) is a more
sensitive indicator of CVD risk than either LDL-C or
non-HDL-C, which measured LDL particles based on
nuclear magnetic resonance in 3066 middle-aged white
participants (53% women) without CVD [2] . In another
study, nuclear magnetic resonance-measured LDL-P
was decreased 5% by gemfibrozil. This reduction was
caused by a significant 20% decrease in the number of
small LDL particles, though no changes in LDL-C were
observed [23]. Moreover, a growing body of evidence
suggests that fibrates increase LDL particle size and
modify LDL subclasses distribution from small, dense
particles to large LDL particles, and reduce the number
of small LDL particles in patients with hypertriglyceri-
demia and the metabolic syndrome [24] . Unfortunately,
the effect of statins on the LDL-P is limited. All these
observations provide support for the concept that there
still remains a high residual risk for vascular disease even
when LDL-C is well-controlled. In this sense, sdLDL
should be considered as a stronger predictor for mac-
rovascular disease than LDL-C. Therefore, although
achieving the LDL target level is the first priority for
therapy in most current guidelines for lipid treatment,
more attention should be given to sdLDL in the Chinese
population [25] .
The third major finding in our study was that
carotid IMT was not correlated with HDL-C or HDL
particle subclasses. Our findings agreed with the
results that higher levels of HDL2 prevent the pro-
gression of carotid IMT in Japanese-Americans [1 2] .
Recent studies have also shown that the inverse asso-
ciation of HDL-C with CHD disappeared after adjust-
ment of apoAI and apoB, while HDL particle number
(HDL-P) remained inversely related with CHD. Thus,
the anti-atherogenic effects of HDL particles may be
related to HDL’s protein or antioxidant enzyme rather
than to its cholesterol concentration [26 ]. HDL asso-
ciated enzyme had the properties of antioxidant anti-
atherosclerosis. Indeed, in the European Prospective
Investigation into Cancer (EPIC)-Norfolk, the HDL-
associated antioxidant paroxonase-1 was positively cor-
related with HDL-P more strongly than with HDL-C
or apoAI [2 7]. Furthermore, in the clinical trials, the
roles of HDL-C and HDL subclasses on vascular dis-
ease were still inconclusive. In a Action to Control
Cardiovascular Risk in Diabetes (ACCORD)-lipid
trial, the combination of fenofibrate plus simvastatin
was compared with simvastatin monotherapy, sug-
gesting that fenofibrate has been associated with a
significant reduction of microvascular complications
in patients with Type 2 diabetes, including the pro-
gression of nephropathy and retinopathy [9] . This is
also in accordance with the Fenofibrate Intervention
and Event Lowering in Diabetes study and Diabetes
Atherosclerosis Intervention Study, which showed that
the progression for microalbuminuria and the need for
laser treatment for diabetic retinopathy could be fur-
ther reduced [2 8, 29] . Taken together, these studies sug-
gest that fenofibrate may prevent microvascular events
but has little effect on macrovascular disease as a whole
[9]. It seems possible that these results are due to the
redistribution of HDL subclasses by fenofibrate. A fur-
ther study with more focus on the relationship between
HDL subclasses and microvascular events is therefore
suggested. However, a 31% reduction in cardiovascu-
lar event rate with combination therapy was observed
in a predefined subgroup of participants with the com-
bination of significant hypertriglyceridemia and low
HDL-C experienced [30] . Unfortunately, it has not
been adjusted by the redistribution of LDL particles by
fenofibrate. Thus, the relationship between HDL sub-
classes and macrovascular disease still remains highly
uncertain [22].
Conclusion
sdLDL was a strong predictor for carotid atherosclerosis
in the general Chinese population. Moreover, HDL-C
future science group
Association of lipoprotein subclasses & carotid intima-media thickness in the Chinese population Research Article
414 Clin. Lipidol.(2014) 9(4)
or HDL subclasses remained free from carotid
atherosclerosis.
Acknowledgements
We would like to thank China Japan Friendship Hospital and
the First People’s Hospital of Longquan for par ticipating in this
st udy, an d fo r col lec t in g dem o gra ph ic da ta an d blo od sa m pl e s.
Financial & competing interests disclosure
This study was suppor ted by grants from the Chinese Medical
Association Foundation and Chinese Diabetes Society
(No. 07020 470055 ). The authors have no other relevant
afliations or nancial involvement with any organization or
entity with a nancial interest in or nancial conict with the
subject matter or materials discussed in the manuscript apart
from those disclosed.
No writing assistance was utilized in the production of this
manuscript.
Ethical conduct of research
The authors state that they have obtained appropriate
insti tutional review board approval or have followed the
princi ples outlined in the Declaration of Helsinki for all
human or animal experimental investigations. In addition, for
investi gations involving human subjects, informed consent
has been obtained from the participants involved.
References
1 Koba S, Yokota Y, Hirano T, Ito Y, Ban Y. Small LDL-
cholesterol is superior to LDL -cholesterol for determining
severe coronary atherosclerosis. J. Atheroscler. Throm. 15 (5) ,
250–260 (2008).
2 Cromwell WC, Otvos JD, Keyes MJ et al. LDL particle
number and risk of future cardiovascular disease in the
Framingham Offspring Study – implications for LDL
mana gement. J. Clin. Lipidol. 1(6), 583–592 (2007).
3 Berneis K, Jeanneret C, Muser J, Felix B, Miseres AR.
Low-density lipoprotein size and subclasses are markers of
clinically apparent and non-apparent atherosclerosis in Type 2
diabetes. Metabolism 54(2), 227–234 (2005).
4 Grundy SM, Cleeman JI, Merz CN et al. Implications of
recent clinical trials for the National Cholesterol Education
Program Adult Treatment Panel III guidelines. J. Am. Coll.
Cardiol. 44(3), 720–732 (20 04).
5 Navab M, Ananthara maia h GM, Fogelman AM. The role of
high-density lipoprotein in inflammation. Trends. Cardiovasc.
Med. 15 (4), 158–161 ( 2005 ).
6 Asztalos BF, Tani M, Schaefer EJ. Metabolic and functional
relevance of HDL subspecies. Curr. Opin. Lipidol. 22(3),
176–185 (2011).
7 Hirayama S, Miida T, Miyazaki O, A izawa Y. Pre beta1-HDL
concentration is a predictor of carotid atherosclerosis in Type 2
diabetic patients. Diabetes Care 30, 1289–1291 (2007).
8 Krauss R M. Lipoprotein subfractions and cardiovascular
disease risk. Curr. Opin. Lipidol. 21(4), 305–311 (2010).
9 The ACCORD study group. Effects of combination lipid
therapy in Type 2 diabetes mellitus. N. Engl. J. Med. 36 2 (17),
156 3 –1574 (2010 ) .
10 Superko HR, Pendyala L, Williams PT, Momary KM, King
SB, Garrett BC. High-density lipoprotein subclasses and their
relationship to cardiovascular disease. J. Clin. Lipidol. 6(6),
496 –523 (2012 ).
11 Alagona C, Soro A, Ylitalo K, Salonen R, Sa lonen JT,
Taskinen MR . A low high density lipoprotein (HDL) level
is associated with carotid artery intima-media thickness in
asymptomatic members of low HDL families. Atherosclerosis
165(2), 309–316 (2002).
12 Maeda S, Nak anishi S, Yoneda M et al. Associations between
small dense LDL, HDL subfractions (HDL2, HDL3) and
risk of atherosclerosis in Japanese-Americans. J. Atheroscler.
Thromb. 19(5), 444–452 (2012).
13 Yang W, Lu J, Weng J et al. Prevalence of diabetes among men
and women in China. N. Engl. J. Med. 362 (12), 1090 –1101
(2010) .
14 Xu Y, Fu M. Alterations of HDL subclasses in hyperlipidemia.
Clin. Chim. Acta 332(1–2), 95–102 (2003).
15 Friedewald W, Lev y R, Fredrickson D. Estimation of the
concentration of low-density lipoprotein cholesterol in plasma,
without use of the preparative ultracentrifuge. Clin. Chem.
18(6), 499 –502 (1972).
16 O’Leary DH, Polak JF, Kronmal R A et al. Thickening of the
carotid wall: a marker for atherosclerosis in the elderly? Stroke
27(2), 224–231 (1996).
17 Nichols AV, Krauss RM, Musliner TA. Nondenaturing
polyacrylamide gradient gel electrophoresis. Methods Enzymol.
128, 417–431 (1986).
18 Tanaka F, Makita S, Onoda T. Predictive value of lipoprotein
indices for residual risk of acute myocardial infarction and
sudden death in men with low-density lipoprotein cholesterol
levels <120 mg/dl. Am. J. Cardiol . 112(8 ), 1063 –1068 ( 2013 ).
future science group
Research Article Yan, Tian, Yu et al.
Executive summary
• Low-density lipoprotein-cholesterol (LDL-C) /high-density lipoprotein-C (HDL-C) ratio is a good indicator for
the distribution of lipoprotein subclasses.
• Small dense LDL was positively correlated with triglycerides levels.
• Total cholesterol and LDL-C were significantly correlated with intima-media thickness.
• Triglycerides and HDL-C were not related with intima-media thickness.
• HDL subclasses did not correlate with carotid atherosclerosis.
• Small dense LDL was a stronger predictor for carotid atherosclerosis than LDL-C.
www.futuremedicine.com 415
19 Tatò F, Vega GL, Tall A R, Grundy SM. Relation between
cholesterol ester transfer protein activities and lipoprotein
cholesterol in patients with hypercholesterolemia and
combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol.
15(1), 112–120 (1995).
20 Charles MA , Kane JP. New molecular insights into CETP
structure and function : a review. J. Lipid Res. 53 (8 ),
1451–1458 ( 2012).
21 Collins R, Armitage J, Parish S et al. Effects of cholesterol-
lowering with simvastatin on stroke and other major
vascular events in 20536 people with cerebrova scular disease
or other high-risk conditions. Lancet 363(9411), 757–767
(2004).
22 Masulli M, Patti L, R iccardi G et al. Relation among
lipoprotein subfractions and carotid atherosclerosis
in Ala skan eskimos (from the GOCADAN Study).
Am. J. Cardiol. 104(11), 1516–1521 (2009).
23 Otvos JD, Collins D, Freedman DS et al. L ow-density
lipoprotein and high-density lipoprotein particle subclasses
predict coronary events and are favorably changed by
gemfibrozil therapy in the Veterans Affairs High-Density
Lipoprotein Intervention Trial. Circulation 113 (12),
1556 –15 63 ( 2006 ).
24 Ikewaki K, Tohyama J-i, Nakata Y, Wakikawa T, Kido T,
Mochizuki S. Fenofibrate effectively reduces remnants, and
small dense LDL, and increases HDL particle number in
hypertriglyceridemic men – a nuclear magnetic resonance
st ud y. J. Atheroscler. Thromb. 11(5), 278–285 (2004).
25 Rosenson RS, Otvos JD, Freedman DS. Relations of
lipoprotein subclass levels and low-density lipoprotein size
to progression of coronar y artery disease in the pravastatin
limitation of atherosclerosis in the coronar y arteries
(PLAC-I) trial. Am. J. Cardiol. 90 (2), 89–94 (2002).
26 van der Steeg WA, Holme I, Boekholdt SM et al . High-
density lipoprotein cholesterol, high-density lipoprotein
particle size, and apolipoprotein A-I: significance for
cardiovascular risk: the IDEAL and EPIC-Norfolk studies.
J. Am. Coll . Cardiol. 51(6), 634 642 (2008).
27 El Harchaoui K, Arsenault BJ, Franssen R et al. High-
density lipoprotein particle size and concentration and
coronar y risk. Ann. Intern. Med. 150(2), 84–93 (2009).
28 Keech AC, Mitchell P, Summanen PA et al. Effect of
fenofibrate on the need for laser treatment for diabetic
retinopathy (FIELD study): a randomised controlled trial.
Lancet 370 (9600 ), 1687–1697 (2007).
29 Ansquer J-C, Foucher C, Rattier S, Taskinen MR, Steiner
G, DAIS Investigators. Fenofibrate reduces progression
to microalbuminuria over 3 years in a placebo-controlled
study in Type 2 diabetes: Results from the Diabetes
Atherosclerosis Intervention Study (DAIS). Am. J. Kidney
Dis. 45(3), 485–493 (2005).
30 Scott R, O’Brien R, Fulcher G et al. Effects of fenofibrate
treatment on cardiovascular disease risk in 9,795 individuals
with Type 2 diabetes and va rious components of the
metabolic syndrome : the Fenofibrate Intervention and Event
Lowering in Diabetes (FIELD) study. Diabetes Care 32(3),
493– 498 (2009 ).
future science group
Association of lipoprotein subclasses & carotid intima-media thickness in the Chinese population Research Article
... In line with this, it has been reported that sdLDL was predictor of the increase of cIMT and IR in patients with prediabetes and T2D 8 . Even more, it was shown that sdLDL was better predictor of carotid atherosclerosis than HDL subclasses 26 . ...
Article
Full-text available
Objective: Determination of lipoprotein size and subclasses distribution can provide more significant information on cardiovascular disease risk than measurement of traditional lipid parameters alone. Accordingly, we aimed to examine their potential relationship with the novel biomarker of endothelial dysfunction, such as endocan in patients with type 2 diabetes mellitus (T2D), since there are no studies concerning this issue. Patients and methods: This case-control study included a total of 42 individuals with T2D and 64 diabetes-free participants. Serum endocan, lipid parameters, and lipoprotein subclasses were measured. Results: Patients with T2D exhibited higher proportion of the smallest high-density lipoprotein (HDL) particles HDL 3c, as compared with diabetes-free participants (p=0.047). Higher serum endocan levels in T2D patients with low small dense low-density lipoprotein (LDL) particles (sdLDL) %, as compared with corresponding group of diabetes-free subjects was shown (p<0.01). Univariate binary logistic analysis revealed significant positive association of endocan and LDL diameter (OR=1.686, p=0.004), and negative associations of endocan with proportions of sdLDL (OR=0.928, p=0.007) and HDL3b (OR=0.789, p=0.009) particles. In a multivariate analysis, LDL diameter and proportions of sdLDL and HDL3b subclasses remained independent predictors of endocan levels in tested population. Conclusions: The results of our study showed that larger LDL diameters, but lower sdLDL and HDL3b proportions were associated with higher endocan levels in population with T2D. More studies in the future are needed to confirm the observed relationship and to examine its causal nature.
... 11 Increases in cIMT are accompanied by a higher incidence of CV morbidity including coronary artery disease, myocardial infarction [12][13][14] and stroke. 15 Although low HDL-C has been associated with increased cIMT, 16 this relationship is not always observed, 17 suggesting that total HDL may not entirely explain HDL's antiatherogenic properties. Also, the association of HDL-C subfractions and cIMT remains disputed since different results are obtained with the use of different separation methods. ...
Article
Full-text available
Introduction: High-density lipoprotein cholesterol comprises a group of heterogeneous subfractions that might have differential effects on atherosclerosis. Moreover, prior investigations suggest that the presence of diabetes (T2D) modifies the impact of some subfractions on atherosclerosis. In this study, we aimed to evaluate the association between high-density lipoprotein cholesterol subfractions and carotid intima-media thickness in the baseline assessment of the Brazilian Longitudinal Study of Adult Health participants from the São Paulo investigation centre. Methods: We evaluated 3930 individuals between 35 and 74 years without previous cardiovascular disease not using lipid-lowering drugs. High-density lipoprotein cholesterol subfractions (HDL2-C and HDL3-C) were measured by vertical ultracentrifugation (vertical auto profile). The relationship between each high-density lipoprotein cholesterol subfraction and carotid intima-media thickness was analysed by multiple linear regression models. Results: Total high-density lipoprotein cholesterol, as well as HDL2-C and HDL3-C, was negatively associated with carotid intima-media thickness after adjustment for demographic data (all p < 0.001) and traditional risk factors (all p < 0.05). When stratified by T2D status, the HDL2-C/HDL3-C ratio showed a negative association with carotid intima-media thickness in participants with T2D ( p = 0.032), even after fully controlling for confounding variables, including total high-density lipoprotein cholesterol. Conclusion: HDL2-C, HDL3-C and HDL2/HDL3-C ratio are inversely associated with carotid intima-media thickness after adjustment for traditional risk factors. Association of the HDL2-C/HDL3-C ratio is modified by the presence of diabetes, being more pronounced in diabetic individuals.
... Previous studies have discovered an increasing pattern of c-IMT with increasing LDL in IBDs (6,24), but our systematic review, which had concentrated on the UCs did not indicate the exact same results. One study had not reported LDL (15) and from the four studies that did report the LDL, three of them followed the aforementioned pattern (1, 16,18), however, one did not (17). ...
Article
Full-text available
Background: Early detection of atherosclerosis is an essential means of decreasing cardiovascular events and its associated mortality. Systemic inflammatory diseases such as ulcerative colitis (UC), are thought to be a contributing factor to atherosclerosis due to the rise of inflammatory cytokines. Objective: The aim of this systematic review and meta-analysis was to assess the association between atherosclerosis and UC. Methods: This systematic review and meta-analysis was performed in February 2017 with no date restrictions. PubMed, Cochrane Library and Embase were searched to discover all available observational studies on atherosclerosis among UC patients. The STROBE criteria were used to assess the quality of the included articles. Heterogeneity was assessed by the I-square statistic and publication bias with funnel plot and Egger’s regression test. Overall summary mean difference was calculated as study effect size using random effect model. Comprehensive Meta-Analysis Software version 2.2 was used to perform analyses. Results: A total of 5 articles met our eligibility criteria. We included a sum of 206 UC patients and 229 non-UC individuals in our review with a mean difference of c-IMT ranged from 0.03±0.0 to 0.16±0.03 mm, and a pooled mean difference of 0.127 mm (95% CI 0.058–0.195: I2 =90.266%). Potential publication bias did not exist for the UC. Conclusion: Our findings showed significant differences in carotid intima-media thickness among UC and Non-UC groups, making c-IMT a viable choice as a predicting marker for atherosclerosis. Thus, we suggest that policy makers assess and consider its application in future protocols for the follow up and management of UC patients. Keywords: Inflammatory bowel disease, Ulcerative colitis, Carotid intima-media thickness, Atherosclerosis, Cardiovascular disease
Article
We evaluated the differences in major markers of cardiovascular (CV) risk between inflammatory bowel diseases (IBDs) and controls by a systematic review and a meta-analysis. We searched PubMed, EMBASE, and Cochrane databases for literature comparing CV risk markers in IBDs and controls. The overall mean carotid intima–media thickness (CIMT), flow-mediated dilation (FMD%), and carotid–femoral pulse wave velocity (cfPWV) difference between patients with IBDs and control groups were calculated. Twenty-eight studies were included in the meta-analysis, including 16 studies with data on CIMT, 7 studies reporting FMD%, and 9 studies on cfPWV. Compared to controls, patients with IBDs showed significantly higher CIMT (standardized mean difference [SMD]: 0.534 mm; 95% confidence interval [CI], 0.230 to 0.838; P = .001), significantly lower FMD% (SMD, −0.721%; 95% CI, −1.020 to −0.421; P < .0001), and significantly increased cfPWV (SMD, 0.849; 95% CI, 0.589 to 1.110; P < .0001). When analyzing subgroups with ulcerative colitis and Crohn disease (CD), all results were still significant except CIMT in CD. Our findings support the current evidence for an elevated CV burden in patients with IBD and support the clinical utility of markers of subclinical atherosclerosis in the management of these patients.
Article
Full-text available
Cholesteryl ester transfer protein (CETP) is important clinically and is the current target for new drug development. Its structure and mechanism of action has not been well understood. We have combined current new structural and functional methods to compare with relevant prior data. These analyses have led us to propose several steps in CETP's function at the molecular level, in the context of its interactions with lipoproteins, e.g., sensing, penetration, docking, selectivity, ternary complex formation, lipid transfer, and HDL dissociation. These new molecular insights improve our understanding of CETP's mechanisms of action.
Article
Full-text available
Small dense low-density lipoprotein (sdLDL) has been suggested to be more atherogenic than large buoyant LDL. High-density lipoprotein (HDL) consists of two major subfractions (HDL2, HDL3), and just as controversy remains regarding which of the two is the more powerful negative risk factor for atherosclerosis, associations between sdLDL and these HDL subfractions are unclear. We measured sdLDL cholesterol (sdLDL-C), HDL2 cholesterol (HDL2-C) and HDL3 cholesterol (HDL3-C) by a newly developed method in 481 Japanese-Americans who were not using lipid-lowering medication, and examined the associations of these cholesterol concentrations with variables related to atherosclerosis. In multivariate analysis, sdLDL-C was positively correlated with the body mass index (BMI), fasting glucose and insulin, 2-h glucose, HOMA-IR, high sensitivity C-reactive protein (hsCRP), and carotid artery intima-media thickness (IMT) after adjustment for age and sex. In particular, sdLDL-C was positively correlated with IMT, even after adjustment for sex, age, smoking status, hypertension, diabetes mellitus and hsCRP. HDL2-C was more closely inversely correlated than total HDL-C with BMI, fasting glucose and insulin, 2-h glucose, HOMA-IR, and hsCRP, whereas HDL3-C was not correlated with these factors. Additionally, HDL2-C was more closely correlated than total HDL-C or HDL3-C with sdLDL-C, LDL-C, triglycerides (TG), and apolipoprotein B (apoB). SdLDL-C was closely associated with insulin resistance and glucose tolerance, lending credence to its potential as a useful risk marker in assessing carotid artery IMT and the present degree of atherosclerosis in Japanese-Americans. The findings also suggest that subjects with higher HDL2-C levels were better protected from atherosclerosis.
Article
Background and Purpose We investigated the relationships between prevalent coronary heart disease (CHD), clinically manifest atherosclerotic disease (ASD), and major established risk factors for atherosclerosis and intima-media thickness (IMT) in the common carotid arteries (CCA) and internal carotid arteries (ICA) separately and in combination in older adults. We wished to determine whether a noninvasive measurement can serve as an indicator of clinically manifest atherosclerotic disease and to determine which of the two variables, CCA IMT or ICA IMT, is a better correlate. Methods IMT of the CCA and ICA was measured with duplex ultrasound in 5117 of 5201 individuals enrolled in the Cardiovascular Health Study, a study of the risk factors and the natural history of cardiovascular disease in adults aged 65 years or more. Histories of CHD, peripheral arterial disease, and cerebrovascular disease were obtained during baseline examination. Risk factors included cholesterol levels, cigarette smoking, elevated blood pressure, diabetes, age, and sex. Relationships between risk factors and IMT were studied by multiple regression analysis and canonical variate analysis. Prediction of prevalent CHD and ASD by IMT measurements in CCAs and ICAs were made by logistic regression, adjusting for age and sex. Results IMT measurements of the CCAs and ICAs were greater in persons with CHD and ASD than those without, even after controlling for sex ( P <.001). IMT measurements in the ICA were greater than those in the CCA. Risk factors for ASD accounted for 17% and 18% of the variability in IMT in the CCA and ICA, respectively. These same risk factors accounted for 25% of the variability of a composite measurement consisting of the sum of the ICA IMT and CCA IMT. The ability to predict CHD and ASD was greater for ICA IMT (odds ratio [confidence interval]: 1.36 [1.31 to 1.41] and 1.35 [1.25 to 1.44], respectively) than for CCA IMT (1.09 [1.05 to 1.13] and 1.17 [1.09 to 1.25]). Conclusions Whereas CCA IMT is associated with major risk factors for atherosclerosis and existing CHD and ASD in older adults, this association is not as strong as that for ICA IMT. The combination of these measures relates more strongly to existing CHD and ASD and cerebrovascular disease risk factors than either taken alone.
Article
Several epidemiologic studies have demonstrated that plasma low-density lipoprotein cholesterol (LDL-C) profile is a key risk indicator for coronary heart disease (CHD). However, almost half of all patients with CHD have normal LDL-C levels. A total of 7,931 male subjects aged ≥40 years from the general population with no cardiovascular history and no use of lipid-lowering agents were followed for incidence of acute myocardial infarction (AMI) and sudden death. Of the 4,827 participants with LDL-C levels <120 mg/dl, 55 subjects had a first AMI/sudden death during an average of 5.5 years of follow-up. After adjustment for confounding factors, multiadjusted hazard ratios (HRs) were increased by 1 SD for non-high-density lipoprotein cholesterol (non-HDL-C; HR = 1.36, 95% confidence interval [CI], 1.02 to 1.81), total cholesterol (TC)/HDL-C ratio (HR = 1.40, 95% CI: 1.11 to 1.78) and LDL-C/HDL-C ratio (HR = 1.32, 95% CI: 1.02 to 1.73) but not for LDL-C (HR = 1.09, 95% CI: 0.82 to 1.44) and HDL-C (HR = 0.84, 95% CI: 0.68 to 1.04). When stratified as categorical variables on the basis of points with highest accuracy on receiver operating characteristic analysis, non-HDL-C levels >126 mg/dl (HR = 1.25, 95% CI: 1.03 to 1.51), TC/HDL-C ratio above 3.5 (HR = 1.22, 95% CI: 1.01 to 1.48) and LDL-C/HDL-C ratio >1.9 (HR = 1.25, 95% CI: 1.04 to 1.51) had increased multiadjusted HRs for AMI/sudden death. In conclusion, in men with LDL-C levels <120 mg/dl, non HDL-C, TC/HDL-C, and LDL-C/HDL-C ratios have predictive value for residual risk of AMI/sudden death.
Article
Background: We investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease. Methods: We randomly assigned 5518 patients with type 2 diabetes who were being treated with open-label simvastatin to receive either masked fenofibrate or placebo. The primary outcome was the first occurrence of nonfatal myocardial infarction, nonfatal stroke, or death from cardiovascular causes. The mean follow-up was 4.7 years. Results: The annual rate of the primary outcome was 2.2% in the fenofibrate group and 2.4% in the placebo group (hazard ratio in the fenofibrate group, 0.92; 95% confidence interval [CI], 0.79 to 1.08; P=0.32). There were also no significant differences between the two study groups with respect to any secondary outcome. Annual rates of death were 1.5% in the fenofibrate group and 1.6% in the placebo group (hazard ratio, 0.91; 95% CI, 0.75 to 1.10; P=0.33). Prespecified subgroup analyses suggested heterogeneity in treatment effect according to sex, with a benefit for men and possible harm for women (P=0.01 for interaction), and a possible interaction according to lipid subgroup, with a possible benefit for patients with both a high baseline triglyceride level and a low baseline level of high-density lipoprotein cholesterol (P=0.057 for interaction). Conclusions: The combination of fenofibrate and simvastatin did not reduce the rate of fatal cardiovascular events, nonfatal myocardial infarction, or nonfatal stroke, as compared with simvastatin alone. These results do not support the routine use of combination therapy with fenofibrate and simvastatin to reduce cardiovascular risk in the majority of high-risk patients with type 2 diabetes. (ClinicalTrials.gov number, NCT00000620.)
Article
To assess the clinical utility of measuring high-density lipoprotein (HDL) subfractions to assess coronary heart disease (CHD) risk. Literature review of 80 published investigations. Measurements of HDL2b by gradient gel electrophoresis provided more consistent evidence of CHD risk than measurement of HDL2 cholesterol. Five of the seven studies that compared the extent or progression of atherosclerosis with gradient gel electrophoresis estimates of HDL subclasses (71%) assigned statistical significance to HDL2b. Ten of the 11 case-control comparisons (91%) reported lower HDL2b in cases. In contrast, of the 16 association studies relating HDL2 cholesterol and HDL3 cholesterol to extent of disease, five reported no significant relationships with either subfraction, two reported significant relationships with both HDL2 and HDL3 cholesterol, four reported significant relationships with HDL2 but not HDL3 cholesterol, and five reported relationships with HDL3 but not HDL2 cholesterol. Forty-five percent of the case-control comparisons reported that both HDL2 cholesterol and HDL3 cholesterol were significantly lower in cases than controls, 17% failed to find significance for either subfraction, and the remainder reported significantly lower values in cases for HDL2 cholesterol only (26%) or HDL3 cholesterol only (11%). On average, the case-control differences were similar for HDL2 (-0.12 ± 0.01 mmol/L) and HDL3 cholesterol (-0.10 ± 0.02 mmol/L), although relative to controls, the percent reduction was twice as great for HDL2 (-25.7 ± 2.9%) than HDL3 cholesterol (-12.1 ± 1.5%). Eight prospective studies were identified and four reported that both HDL2 and HDL3 predicted lower risk for CHD, one reported reductions in risk for HDL2 but not HDL3 cholesterol, and three reported reductions in risk for HDL3 but not HDL2 cholesterol. None of the prospective studies show that measurements of HDL cholesterol subfractions improve the identification of persons at risk. HDL2 and HDL3 cholesterol do not distinguish cardioprotective differences between HDL subclasses. More extensive characterization of HDL particles by one or two dimensional gel electrophoresis, ion mobility, or ultracentrifugation may provide more specific information about CHD risk than the measurement of HDL cholesterol, HDL3 cholesterol, or HDL2 cholesterol.
Article
Our purpose is to review recent findings highlighting the metabolic and functional diversity of HDL subspecies. HDL heterogeneity - both structural and functional - is the main focus of this review. Recent work indicates that the metabolism and functionality of HDL particles differ greatly among HDL subspecies. With the introduction of new and improved methodology (e.g., proteomics), new aspects of the structural complexity and functionality of HDL have been revealed. It has been confirmed that HDL functions - including, but not limited to decreasing inflammation, apoptosis, macrophage adhesion to the endothelium and insulin resistance - are due to HDL's ability to remove cholesterol from cells (reverse cholesterol transport). A new level of HDL complexity has recently been revealed by investigating the lipid composition of HDL with gas chromatography, gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry. There are about 100 different HDL-associated proteins; however, there are many more lipid species potentially associated with HDL particles. The most important recent findings disclose that HDL is more complex than previously thought. HDL subclasses differ in physical-chemical properties, protein and lipid composition, metabolism, physiological functions and pathophysiological significance. The staggering complexity of HDL demands significantly more investigation before we can truly begin to understand HDL metabolism and function in humans.
Article
Subfractions of LDL and HDL defined by differences in particle size and density have been associated to varying degrees with risk of cardiovascular disease (CVD). Assessment of these relationships has been clouded by lack of standardization among the various analytic methodologies as well as the strong correlations of the subfractions with each other and with standard lipid and lipoprotein risk markers. This review summarizes the properties of the major LDL and HDL particle subclasses, and recent evidence linking their measurement with risk of atherosclerosis and CVD. Several recent studies have shown independent relationships of levels of LDL and HDL-size subclasses to risk of both coronary artery and cerebrovascular disease. However, the two largest studies, employing nuclear magnetic resonance and ion mobility, respectively, did not find evidence that these measurements improved risk assessment compared with standard lipoprotein assays. In the latter study, principal component analysis was used to group multiple subfraction measurements into three distinct and statistically independent clusters that were related both to cardiovascular outcomes and to genotypes that may reflect underlying metabolic determinants. Although there is as yet inconclusive evidence as to the extent to which LDL and HDL subfraction measurements improve clinical assessment of CVD risk beyond standard lipid risk markers, recent studies suggest that more refined analyses of lipoprotein subspecies may lead to further improvements in CVD risk evaluation and particularly in identification of appropriate targets for therapeutic intervention in individual patients.